Sjögren's disease trials in Poland

In Poland 9 Also abroad 80

9 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
Where
Bydgoszcz, Cracow, Poznan, Warsaw
Age
18 years and over
People
570 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07621809 · EU 2025-522271-29-00
Phase 2Taking people
A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease
Where
Bydgoszcz, Częstochowa, Poznan, Warsaw
Age
18 years to 100 years
People
344 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07737743 · EU 2025-524513-92-00
Phase 3Taking people
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
Where
Bydgoszcz, Cracow, Gdynia, Katowice, Lodz, Lublin, Malbork, Poznan, Pruszkow, Siedlce, Warsaw, Warszawa, Zamość
Age
18 years to 75 years
People
250 worldwide
Run by
Vor Biopharma
See details and how to joinNCT07404865 · EU 2026-525556-28-00
Phase 1Not yet taking people in Poland
A Study of BMS-986553 in Participants With Refractory Autoimmune Diseases
Where
Bydgoszcz, Krakow, Poznan
Age
18 years and over
People
60 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07873931
Phase 2Not yet taking people in Poland
A Study to Assess Efficacy and Safety of Efgartigimod in Adults With Sjogren's Disease-associated Sensorimotor Polyneuropathy or Sensory Polyneuropathy (SERENITY)
Where
Lublin, Warsaw
Age
18 years and over
People
75 worldwide
Run by
argenx
See details and how to joinNCT07760818 · EU 2026-526218-10-00
Phase 2Taking people
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Where
Bydgoszcz, Lodz, Warsaw
Age
18 years and over
People
90 worldwide
Run by
Artiva Biotherapeutics, Inc.
See details and how to joinNCT06991114 · EU 2025-520461-41-00
Phase 1Taking people
A Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)
Where
Cracow, Poznan, Warsaw
Age
18 years to 70 years
People
44 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT07371468 · EU 2025-522932-15-00
Phase 1Taking people
A Phase 1b, Open-Label Study of CLN-978 for the Treatment of Active, Moderate to Severe Sjogren’s Disease
Where
Cracow, Jozefow, Warsaw
Age
18 years and over
People
40 worldwide
Run by
Cullinan Therapeutics Inc.
See details and how to join2025-521462-96-00 · EU 2025-521462-96-00
Phase 3Taking people
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
Where
Bydgoszcz, Cracow, Katowice, Lodz, Lublin, Malbork, Poznan, Warsaw, Wołomin, Wroclaw, Wrocław
Age
18 years and over
People
844 worldwide
Run by
Amgen
See details and how to joinNCT06747949 · EU 2024-517513-32-00